A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior
Conditions: Cigarette Smoking-Related Carcinoma Interventions: Drug: Nicotine Replacement; Other: Questionnaire Administration; Device: Vaping; Device: Vaping Sponsors: Ohio State University Comprehensive Cancer Center; National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
Implementing Screening for Cannabis and Other Drug Use Disorders in Primary Care: Impact on Diagnosis and Treatment
Conditions: Cannabis-Related Disorder; Cannabis Abuse; Drug Abuse; Drug Use Disorders; Opioid Use Disorder; Opioid Abuse; Substance Abuse; Substance Use Disorders Interventions: Other: Care Delivery Improvement Intervention Sponsors: Kaiser Permanente; National Institute on Drug Abuse (NIDA) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Evaluation of Abuse Potential of HORIZANT Taken Alone and With Oxycodone in Healthy, Nondependent Recreational Opioid Users
Conditions: Abuse Potential Interventions: Drug: Placebo; Drug: Oxycodone 20 mg; Drug: GE-IR 200 mg + Oxycodone 20 mg; Drug: GE-IR 450 mg + Oxycodone 20 mg; Drug: GE-IR 200 mg; Drug: GE-IR 450 mg Sponsors: Azurity Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
TAU vs m-SBIRT in Primary Care
Conditions: Substance Use Disorders Interventions: Behavioral: m-SBIRT (mobile-Screening, Brief Intervention, and Referral to Treatment) Sponsors: Medical University of South Carolina; National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Effects of Tobacco Cut and Nicotine Form on the Abuse Liability of Moist Snuff
Conditions: Tobacco-Related Carcinoma Interventions: Procedure: Biospecimen Collection; Procedure: Carbon Monoxide Measurement; Behavioral: Smokeless Tobacco Use; Other: Survey Administration Sponsors: Ohio State University Comprehensive Cancer Center; National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
$9 million NIH grant advances drug to treat nicotine addiction
SAN DIEGO, Feb. 6, 2024. Scientists at Camino Pharma, LLC, Sanford Burnham Prebys and University of California San Diego School of Medicinereceived a $9-million grant (U01DA057847) from the National Institute on Drug Abuse (NIDA) at the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 6, 2024 Category: Pharmaceuticals Source Type: clinical trials
A Study to Test the Effects of Kindolor at Different Doses in Healthy Adults
Conditions: Chronic Pain Interventions: Drug: Kindolor Tosylate; Drug: Placebo Sponsors: Lohocla Research Corporation; National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Modeling Tobacco Regulatory Impacts in Appalachia Using the Experimental Tobacco Marketplace
Conditions: Tobacco Use; Cigarette Use Interventions: Drug: Very Low Nicotine Cigarette; Behavioral: Reduced nicotine regulatory environment; Behavioral: Restriction on characterizing flavors in combustible nicotine products; Behavioral: Restriction on characterizing flavors in noncombustible nicotine products Sponsors: Mikhail N Koffarnus; National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
Conditions: Methamphetamine-dependence; Methamphetamine Abuse Interventions: Drug: extended-release naltrexone (XR-NTX); Drug: extended release bupropion (BUP-XL) tablets (BUP-XL); Drug: iPLB; Drug: oPLB Sponsors: National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
LIFU for Treatment for Refractory Opioid Use Disorder
Conditions: Opioid Use Disorder Interventions: Device: Low Intensity Focussed Ultrasound Sponsors: Ali Rezai; National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
Delta-8-THC vs. Delta-9-THC on Simulated Driving Performance
Conditions: Cannabis Interventions: Drug: Delta-9-THC; Drug: Delta-8-THC; Drug: Placebo Sponsors: Johns Hopkins University; Substance Abuse and Mental Health Services Administration (SAMHSA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
A Phase 1, Placebo-controlled, Single-Ascending-Dose, Study of BIOPIN 6 in Healthy Adults
Conditions: Opioid Use Disorder Interventions: Combination Product: BIOPIN-6 Active Implant with Naltrexone; Device: BIOPIN-6 Placebo Implant Sponsors: Drug Delivery Company, LLC DBA Akyso Pharmaceuticals; National Institute on Drug Abuse (NIDA); Laboratory Corporation of America; Cognitive Research Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
SafeMedWaste At-Home, Environmentally-Friendly Opioid Disposal Kit for Orthopedic Post-Operative Surgical Patients to Reduce Opioids Available for Diversion
Conditions: Opioid Use Disorder Interventions: Device: SafeMedWaste Sponsors: SafeMedWaste, Inc.; Prisma Health-Midlands; University of South Carolina; National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
KIOS Mobile App Evaluation
Conditions: Opioid Use Disorder Interventions: Device: KIOS App; Behavioral: KIOS App education; Behavioral: Treatment as usual Sponsors: The University of Texas Health Science Center at San Antonio; National Institute on Drug Abuse (NIDA); Biomedical Development Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Mobile Technologies Extending Reach of Primary Care for Substance Use Disorders
Conditions: Substance-Related Disorders Interventions: Device: SBIRT/eIntervention for those with moderate risk drug or alcohol use; Device: SBIRT/eIntervention those assessed with high risk.; Other: SBIRT/TAU for those with moderate risk drug or alcohol use; Other: SBIRT/TAU for those assessed with high risk. Sponsors: Chess Mobile Health; National Institute on Drug Abuse (NIDA); Western Michigan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
